AbbVie Inc. (ABBV)
AbbVie Inc. Return on Invested Capital (ROIC)
| Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (ROIC) | 0.0% | 25.2% | 21.5% | 39.9% | 28.8% | 19.6% | 22.5% | 16.1% | 13.8% | 12.2% | 28.2% | 11.6% | 12.9% | 13.7% | 10.3% |
AbbVie Inc. (ABBV) Return on Invested Capital (ROIC) comparison analysis
ABBV key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is AbbVie Inc.'s Return on Invested Capital (ROIC)?
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 9.9%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for AbbVie Inc. have been 11.5% over the past three years, and 13.5% over the past five years.
2) Is AbbVie Inc.'s Return on Invested Capital (ROIC) Good?
As of today, AbbVie Inc.'s Return on Invested Capital (ROIC) is 9.9%, which is lower than industry median of 13.6%. It indicates that AbbVie Inc.'s Return on Invested Capital (ROIC) is Bad.